CA1100874A - Traduction non-disponible - Google Patents

Traduction non-disponible

Info

Publication number
CA1100874A
CA1100874A CA282,723A CA282723A CA1100874A CA 1100874 A CA1100874 A CA 1100874A CA 282723 A CA282723 A CA 282723A CA 1100874 A CA1100874 A CA 1100874A
Authority
CA
Canada
Prior art keywords
compound
composition according
organosulfoxide
group
sulfoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA282,723A
Other languages
English (en)
Inventor
Lawrence Flora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of CA1100874A publication Critical patent/CA1100874A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA282,723A 1976-07-15 1977-07-14 Traduction non-disponible Expired CA1100874A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70565076A 1976-07-15 1976-07-15
US705,650 1985-02-26

Publications (1)

Publication Number Publication Date
CA1100874A true CA1100874A (fr) 1981-05-12

Family

ID=24834378

Family Applications (1)

Application Number Title Priority Date Filing Date
CA282,723A Expired CA1100874A (fr) 1976-07-15 1977-07-14 Traduction non-disponible

Country Status (9)

Country Link
JP (1) JPS5334930A (fr)
AU (1) AU2649977A (fr)
BE (1) BE856849A (fr)
CA (1) CA1100874A (fr)
DE (1) DE2731366A1 (fr)
FR (1) FR2358153A1 (fr)
GB (1) GB1582694A (fr)
NL (1) NL7707849A (fr)
NZ (1) NZ184496A (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59117882A (ja) * 1982-12-25 1984-07-07 Kazuo Hashimoto ドア−スコ−プ
JPS59148479A (ja) * 1983-02-14 1984-08-25 Aihon Kk 集合住宅用テレビ・インタ−ホンシステム
JPS6139788A (ja) * 1984-07-31 1986-02-25 Toshiba Electric Equip Corp 集合住宅インタ−ホンシステム
JPH0822059B2 (ja) * 1985-02-07 1996-03-04 アイホン株式会社 テレビ通話装置
JPS63234792A (ja) * 1987-03-24 1988-09-30 Izumi Soken Eng:Kk 無人受付案内システム
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
US5139786A (en) * 1989-07-07 1992-08-18 Ciba-Geigy Corporation Topical formulations
US7820197B2 (en) 2002-02-14 2010-10-26 Astellas Pharma Inc. Percutaneous preparations
US20090239828A1 (en) 2006-09-11 2009-09-24 Yuuhiro Yamazaki Adhesive preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH9853A (en) * 1972-06-08 1976-04-13 M Francis Compositions for inhibiting mobilization of calcium phosphate in animal tissue and method of use thereof

Also Published As

Publication number Publication date
DE2731366A1 (de) 1978-01-19
FR2358153A1 (fr) 1978-02-10
NL7707849A (nl) 1978-01-17
JPS5334930A (en) 1978-03-31
NZ184496A (en) 1980-08-26
FR2358153B1 (fr) 1979-05-11
AU2649977A (en) 1979-01-04
BE856849A (fr) 1978-01-16
GB1582694A (en) 1981-01-14

Similar Documents

Publication Publication Date Title
KR100866025B1 (ko) 통증 치료를 위한 비스포스포네이트의 용도
Reynolds et al. The effect of two diphosphonates on the resorption of mouse calvaria in vitro
EP1296689B1 (fr) Methode d'administration de bisphosphonates
Kanis et al. Rationale for the use of alendronate in osteoporosis
CA1100874A (fr) Traduction non-disponible
NZ190819A (en) Stabilised radiographic scanning agents
US4330530A (en) Anti-arthritic compositions and method using gold salts and organophosphonates
US4086334A (en) Composition and method for the treatment of disorders of calcium metabolism
DK156412B (da) Praeparat til fremstilling af et technetiumbaseret knoglemineral- eller infarktscanningsmiddel
NZ241717A (en) Manufacture of medicament to treat osteoporosis comprising bone-active phosponate and low dosage estrogen
US4269828A (en) Indole anti-inflammatory composition
CA1174602A (fr) Compose pharmaceutique pour le traitement des ostheopathies
US4216212A (en) Pyrazolidine anti-inflammatory composition and methods of use
EP0994884B1 (fr) Sels d'acide diphosphonique pour le traitement de l'osteoporose
US4446052A (en) Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
US4282214A (en) Phenylacetate anti-inflammatory composition
JP3883137B2 (ja) ピリジルビスホスホン酸エステルよりなる治療用活性薬剤
EP0088462A2 (fr) Composition anti-inflammatoire et anti-rhumatisante contenant un organophosphonate et un stéroide
KR100385697B1 (ko) 올파드로네이트를포함하는골체량동화성조성물
JPH0640914A (ja) フィソスチグミンの新誘導体、それらの用途及びそれらを含む製薬組成物
Watt et al. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat
IE47042B1 (en) Anti-inflammatory drug based on phosphonates plus other anti-inflammatories
EP1536803A2 (fr) Utilisation de derives d'acide biphosphonique pour le traitement de maladies associees au depot de diphosphate de calcium et traitement dentaire
CA1067823A (fr) Compose et methode pour le traitement des troubles du metabolisme du calcium
NZ209953A (en) 99m technetatemethanehydroxydiphosphonate

Legal Events

Date Code Title Description
MKEX Expiry